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REVIEW

Thrombus formation: direct real-time observation and digital
analysis of thrombus assembly in a living mouse by confocal
and widefield intravital microscopy
A. CELI,1 G. MERRILL-SKOLOFF, P. GROSS, S. FALATI, D. S. SIM, R. FLAUMENHAFT,
B . C . F U R I E and B . F U R I E
Center for Hemostasis and Thrombosis Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA

Summary. We have developed novel instrumentation using
confocal and widefield microscopy to image and analyze
thrombus formation in real time in the microcirculation of a
living mouse. This system provides high-speed, near-simultaneous acquisition of images of multiple fluorescent probes and a
brightfield channel, and supports laser-induced injury through
the microscope optics. Although this imaging facility requires
interface of multiple hardware components, the primary challenge in vascular imaging is careful experimental design and
interpretation. This system has been used to localize tissue
factor during thrombus formation, to observe defects in thrombus assembly in genetically altered mice, to study the kinetics of
platelet activation and P-selectin expression following vascular
injury, to analyze leukocyte rolling on arterial thrombi, to
generate three-dimensional models of thrombi, and to analyze
the effect of antithrombotic agents in vivo.
Keywords: confocal, intravital microscopy, molecular imaging, platelets, tissue factor, thrombus

Introduction
Blood coagulation is a complex and finely regulated host
defense mechanism [1]. Perturbations of this system are
well-recognized causes of diseases such as thrombosis, atherosclerosis, and hemorrhagic disorders. Our current models of the
basic mechanisms of blood coagulation are mostly based on
extrapolations from in vitro experiments. However, our understanding of these phenomena would greatly benefit from the
availability of tools for in vivo observation and analysis. In
recent years, a number of technological breakthroughs in disCorrespondence: Dr Bruce Furie, Center for Hemostasis and Thrombosis
Research, Research East 319, Beth Israel Deaconess Medical Center, 330
Brookline Ave, Boston MA 02215, USA.
Tel.: þ 617 667 0620; fax: þ 617 975 5505,
e-mail: bfurie@caregroup.harvard.edu
1

Present address: Laboratorio di Biologia Cellulare Respiratoria, Dipartimento Cardiotoracico, Università di Pisa, Pisa, Italy.
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parate fields have converged to offer the possibility to address
old questions with new tools. The availability of techniques to
manipulate the genome in mice, thereby generating transgenic,
knockout and knock-in mouse strains, allows identification of
the role of a single gene and its product in specific physiologic
phenomena. This has in turn prompted the development of
mouse models of human disease in order to take advantage of
these genetically engineered animals to study the role of single
proteins in different pathologic conditions, including thrombosis [2]. Intravital microscopy, the microscopic analysis of living
cells, has been widely used and extended to the study of the
microcirculation by many investigators [3]. However, only
recently have advances in microscopy technology made possible the development of a confocal microscope that is capable,
through the use of Nipkow disk technology, of acquiring images
compatible with video-frame rates [4]. Finally, the digital
revolution has fostered the development of relatively inexpensive but powerful computer workstations that can handle rapid
data collection and quickly store massive amounts of image
information in digital format. We took advantage of the availability of these tools to design and assemble instrumentation
that combines high-speed widefield and confocal fluorescence
microscopy with a nitrogen laser that delivers an injury via the
microscope optics to the vascular wall. This instrument provides the ability to image thrombus formation in real time in the
microcirculation of a living mouse. We used fluorescently
labeled antibodies directed against cell-specific or soluble
antigens to study the role of specific cell populations and
proteins in thrombus formation in wild-type mice and in mice
with a spectrum of genetic modifications. To facilitate access to
this technology and its potential for furthering basic and applied
research in blood coagulation and vascular biology, we provide
here a full description of the components of this system and the
methods that we have used to generate and rigorously analyze
data. Since both the hardware, software and user applications
continue to evolve rapidly, the description that follows is
current, but likely to change with continued improvements.
Real-time in vivo imaging
Our system involves the imaging of the cremaster muscle
microcirculation in a living mouse. Although other vascular
windows have been used in our laboratory, including the
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mesenteric microcirculation and the ear microcirculation, the
cremaster muscle offers excellent blood vessel images because
it is thin and transparent, contains many arterioles and venuoles,
and permits a stable preparation for multiple hours of study.
Wild-type mice and genetically altered mice are routinely
employed, and thus provide important information about the
role of particular gene products in thrombus formation. We
employ a laser-induced injury model [5]. Although many other
injury models have been adapted to experiments in the mouse
[2], the laser injury is temporally and spatially defined and its
magnitude adjustable. Confocal imaging employs laser excitation, a high-speed confocal scanner using Nipkow disk technology, and capture of intensified images on a high-speed
digital CCD camera. Widefield imaging involves irradiation
of the specimen with monochromatic light and capture of
intensified images on a high-speed digital CCD camera. The
cameras are software-controlled, acquiring digital video images
at a high frame-rate. These images are analyzed in a computer
workstation following data acquisition.
Mouse model
We use the cremaster muscle model to visualize the microcirculation in mice as described [6]. Briefly, the animal is
anesthetized with an intraperitoneal injection of ketamine
(125 mg kg1), xylazine (12.5 mg kg1), and atropine sulfate
(0.25 mg kg1), and the jugular vein is exposed under a dissecting microscope and cannulated. For some experiments, the
femoral vein is used to introduce reagents into the circulation.
When blood pressure is monitored continuously, a tranducer is
associated with the carotid artery. The trachea is always cannulated to facilitate spontaneous respiration. The animal is then
placed on a custom-designed Plexiglas tray, and the cremaster
muscle is exteriorized through an incision in the scrotum. After
removal of the connective tissue, the muscle is pinned across a
coverslip mounted within the tray. The muscle preparation is
superfused throughout the experiment with preheated (37 8C)
bicarbonate-buffered saline, aerated with 5% CO2/95% N2 and
kept warm on a heated water blanket. The animal is then moved
to the microscope stage. Buffer superfusion is restarted immediately upon repositioning of the animal onto the microscope
stage, and the meniscus generated by the buffer is used to
immerse the lens of the microscope objective. The procedure
described typically requires 5–7 min. Anesthesia is maintained
with Nembutal (50 mg kg1) injected though the jugular vein as
needed. The same access is also used for the injection of
antibodies, fluorochromes, cells, etc.
Cell and protein labeling
Several approaches can be used to visualize the various components of a thrombus in the microcirculation. Each has
advantages and disadvantages. The choice of the wavelength
of the fluorochrome depends on the specific experimental
design and must take into consideration background tissue
autofluorescence, which is maximal at about 500 nm, and the
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presence of other fluorochromes so that crossover, i.e. ‘bleeding’ of the signal generated by one channel into another, can be
minimized or eliminated. When only two fluorescent labels are
present, the use of Alexa 350 or 488 and Alexa 660 usually
represents the best choice; when a third label is introduced, we
use Alexa 350, Alexa 488 and either Alexa 660 or Cy5 (All from
Molecular Probes, Eugene, OR, USA). Since Alexa 567 is
excited by irradiation at 488 nm, we never use Alexa 488 (or
fluoroscein) with Alexa 567 (or rhodamine). Since the excitation spectrum of Alexa 640, Alexa 660 and Cy5 are broad, one
has to consider that excitation of fluorochromes at lower
wavelength may also excite fluorochromes with excitation
maxima at higher wavelengths.
Purified proteins

Purified proteins are labeled in vitro with the optimal fluorochromes, assayed in vitro for biological activity, and then reinfused into the mouse circulation via the jugular catheter. This
requires use of commercially available proteins or necessitates
purification of the critical protein, ideally from mouse tissue.
Conjugation of the protein with a fluorochrome employs standard chemistry and is carried out using the fluorochrome
manufacturer’s instructions. Proper analysis, however, includes
examination by SDS gel electrophoresis to assure protein
migration that is identical or nearly identical to the native,
unlabeled protein; quantitation of fluorescence and calculation
of the average number of fluorochromes per protein molecule;
and assay of the protein for biological activity, either enzyme
assay, binding assay, etc. to demonstrate that the labeling procedure did not impair functional activity. The fluorochromeconjugated protein is infused into the mouse circulation via the
jugular catheter. It is paramount that this labeled protein is functionally equivalent to the unlabeled protein in the mouse plasma,
and neither inhibits nor enhances the activity of the native
protein. In order to realize the fluorescence intensity necessary
for imaging, the amount of protein infused must be significant
relative to the amount of native protein. For example, when we
directly label fibrinogen with Alexa fluors, we infuse sufficient
amounts of labeled fibrinogen so that 10–20% of the total
plasma fibrinogen in the circulation is the labeled fibrinogen.
Purified cells

Blood is obtained by cardiac puncture or carotid cannulation
and collected in acid–citrate–dextrose buffer. Leukocytes are isolated by centrifugation. After centrifugation to obtain plateletrich plasma, platelets are further purified by gel filtration. Cells
are then labeled in vitro with a fluorochrome. Handling of cells
during isolation can potentially perturb cell function, and this
is especially true when working with platelets. Specifically,
in vitro platelet activation can confound experiments in which
labeled platelets are infused back into the circulation in an activated form. When platelets are labeled, platelet suspensions
containing 3  107 platelets mL1 are incubated with calcein
acetoxymethyl ester (0.5 mg mL1; Molecular Probes, Eugene,
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OR, USA) for 25 min at room temperature. Once hydrolyzed
inside the cell, this compound becomes fluorescent and hydrophilic, a characteristic that traps it inside the cell. This method is
particularly useful when platelets from one animal with a specific genotype are injected into an animal with a different genotype. For example, P-selectinþ/þ platelets can be injected into a
P-selectin–/– mouse to investigate the role of platelet-derived Pselectin as opposed to endothelial cell-derived P-selectin. These
platelets are infused into the mouse via the jugular catheter.
Depending upon the particular experiment to be performed, the
labeled platelets represent 0.5–10% of the total circulating
platelets. Calcein AM can also be used to label other blood cells.
Antibody labeling: direct

Antibodies can be directly labeled with various fluorochromes,
and these antibodies infused for in vivo labeling of target
antigens. We prefer the Alexa series of fluorochromes (Molecular Probes), which offer the advantage of a low rate of
photobleaching. Antibodies are labeled by incubating purified
antibody with the label, followed by gel filtration to separate the
labeled antibody, which elutes in the void volume, from the
excess label. In some cases, labeled antibodies are available
commercially, although this limits the choice of both labels and
antibodies. Direct labeling of primary antibody reduces the
number of proteins to be infused and therefore the non-specific
‘trapping’ of molecules within the thrombus. It also reduces the
complexity of interpretation, where there could be concern
about cross-species binding of secondary antibodies. However,
in controlling the experiment by comparison of the signal
generated by the relevant antibody with that generated by a
non-immune control, it is crucial that every antibody has an
isotype-matched control if the primary antibody is monoclonal,
or a non-immune IgG if the primary antibody is polyclonal, with
exactly the same fluorochrome : protein ratio, i.e. molar fluorescence yield. While this is in principle true for all immunochemical assays, it appears to be particularly relevant in this in
vivo model in which non-specific binding cannot be overcome
by more stringent washing steps, for example.
The use of F(ab0 )2 fragments, obtained by pepsin digestion of
the whole IgG molecule followed by affinity chromatography
using a Protein A–Sepharose column to retain the Fc fragments,
is sometimes preferred to reduce the toxic effects of the antibody or to eliminate the potential of antibody–Fc receptor interaction on cell surfaces. Platelet labeling can be achieved by
injecting a fluorescently labeled Fab or F(ab0 )2 fragment of a rat
monoclonal antibody directed against the membrane glycoprotein IIb (CD41). We generally observe that upwards of 70% of
platelets are labeled in vivo, a value determined by flow cytometry of blood platelets removed from the mouse circulation.

labeled antibody. An advantage of this approach is that detection in these experiments using the primary specfic antibody and
the primary control antibody is with the same secondary,
labeled antibody.
Experimental thrombus generation
Several methods have been proposed to induce thrombus formation in mice [2]. In our models, we use a nitrogen dye laser to
injure endothelial cells [5]. The site of the vessel wall to be
injured is established and several images of the field are
captured. The laser beam is then aimed at the endothelial cell
monolayer through a crosshair in the ocular and bursts of laser
light for a predefined time interval are delivered. The power and
frequency of these bursts is empirically determined and depends
on the thickness of the tissues and on the desired size of the
thrombus. For most of our experiments, we have generated
sufficiently accurate data by capturing a few images of the site
to be injured prior to ablation, ablating while looking through
the ocular lenses of the microscope and then rapidly switching
to the camera view while initiating image capture. In this
method, proper barrier filters must be in place when ablating
to avoid eye injury. We have found the thrombi generated by this
method to be more consistent in size than those created by the
alternative method described below. Image capture generally
begins approximately 7 s after the first signs of thrombus
generation are noted. This is the time needed to change emission filters, to alter the camera view and and to intiate data
capture. We have found an alternative method to be ideal: to
begin digital image capture prior to ablation, to continue to
capture images while effecting vessel wall injury and to continuously capture images during thrombus formation. However,
in practice, this can be difficult, but with experience comes skill
in predictably generating a thrombus. Care must be taken to
assure that the emission filter being used absorbs light at the
frequency of the ablation laser so as to avoid stray reflections
that might otherwise damage the intensifier or camera. This
method necessitates that the laser be targeted while looking at
the computer screen rather than through the microscope oculars,
and the software must support real-time video imaging directed
to a monitor. Furthermore, the time lag between the target’s
actual position due to animal movements and its image on the
screen makes successful thrombus formation more difficult.
Thrombi can be generated both in venules and arterioles. The
number of thrombi that can be generated in a single experiment
varies depending on the anatomy of the vessel tree in the
specific mouse preparation. We routinely generate as many
as 10 arteriolar thrombi over the course of a 60–90-min
experiment, moving upstream along the vessels.
Intravital microscopic imaging

Antibody labeling: indirect

Alternatively, labeled anti-immunoglobulin antibodies can be
used for indirect immunofluorescence where the target primary
antibody is detected in vivo with a secondary, fluorescently

Our system was developed around an Olympus AX70 microscope with a trinocular head (Olympus America, Inc., Melville,
NY, USA). Although the microscope has a full set of objectives,
the intravital microscopy applications described here require
# 2003 International Society on Thrombosis and Haemostasis
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mostly a 40  and a 60  water immersion lens (LUMPlanFl/
IR), with numerical apertures of 0.80 and 0.90, respectively.
Transmitted light under the specimen is delivered through a
shutter (Uniblitz VS25, Vincent Associates, Rochester, NY,
USA) with an electromagnetic actuator that can be operated
manually (for example during thrombus generation), or through
computer control during image acquisition. In this latter case,
the brightfield light can be shuttered on and off to allow
brightfield image capture during fluorescent illumination. During widefield microscopy, fluorescent illumination is provided
by a 175-W xenon lamp that can supply light from 350 nm
through 700 nm. In contrast to a mercury lamp, the xenon lamp
provides similar intensity across the excitation spectrum. The
excitation beam is controlled by a high-speed wavelength
changer (DG-4, Sutter Instrument Company, Novato, CA, USA)
that allows switching of the beam position via an electrogalvanometer-controlled mirror to pass through, in sequence,
any of four positions, each with a specific excitation filter.
Switching from one filter to the next is computer-controlled and
is effected in time intervals as short as 1.2 ms. In our instrument,
the DG-4 wavelength changer is equipped with excitation filters
(360 nm, 480 nm and 590 nm; Chroma, Brattleboro, VT, USA)
matched to a triple band pass dichroic emission filter (DAPI/
FITC/Cy5; Chroma) in the microscope. These components
allow near-simultaneous collection of images in up to three
fluorescence channels and a brightfield channel.
For confocal microscopy, we use a Yokogawa CSU-10 confocal scanner (distributed as the PerkinElmer UltraView) based
on Nipkow disk technology. For colocalization experiments,
confocal microscopy as opposed to widefield microscopy is
invaluable for image analysis and quantitation. However,
although out-of-focus haze can be eliminated by confocal
microscopy, the Nipkow disk and short exposure times required
for real-time image acquisition greatly limit light, thus requiring
light amplication with an intensifier. The resulting loss of
resolution degrades the image but allows obtaining optical
sections. This confocal scanner uses the same pinholes for
entrance and exit light beams but is also equipped with a second
rotating disk that contains approximately 20 000 pinholes, each
with a microlens. The disks rotate together at 1800 r.p.m. so that
the light beams raster-scan the specimen. This technology
allows the microscope to capture, in theory, up to 360
frames s1. In contrast, standard point-scanning confocal microscopes have a single pinhole and take about 0.5–1 s to
acquire an image. An argon–krypton three-line laser (Melles
Griot, Carlsbad, CA) provides the fluorescent light for confocal
microscopy, with excitation at 488 nm, 568 nm, and 647 nm. A
filter wheel (Lambda L-10, Sutter Instrument Company, Novato, CA, USA) is mounted on the excitation source to enable
delivery of monochromatic light. The microscope objective is
mounted on a piezoelectric driver (Physiks Instrumente International, Waldbronn, Germany), which is controlled by the
computer and which allows changes in the focal plane as rapidly
as every 20 ms with movements as small as 0.1 mm in the z axis.
To generate laser-induced thrombi, the system is fitted with a
nitrogen ablation laser (MicroPoint, Photonic Instruments, St.
# 2003 International Society on Thrombosis and Haemostasis

Charles, IL, USA) which is introduced via the epi-illumination
port and is focused on the specimen through the microscope
objectives. The output of the laser is at 337 nm but is subsequently tuned through a dye cell. We routinely use coumarin as
dye, which emits at 440 nm. The laser delivers 4-nsec energy
pulses, at typically 3 pulses s1, over a surface approximately
1 mm in diameter; the energy of the pulses can be controlled by
the operator. The laser beam must be periodically aligned with
the crosshair by placing a coated slide onto the stage, checking
where the beam causes the removal of a small area of the
coating relative to the crosshair, and adjusting the alignment.
Our microscope is equipped with a motorized stage (ProScan
101, Prior Scientific, Cambridge, UK) specifically modified to
accommodate our sample tray. The stage, which can be operated either via a manual joystick or through coordinates introduced into the computer, allows precise and reproducible
movement of the animal preparation.
The central part of the trinocular stand is connected to a 12bit CCD videocamera through a Gen III intensifier (Videoscope,
Sterling VA, USA). The intensifier amplifies the signal that
reaches the CCD chip, thus allowing shorter exposures for the
same amount of available light. This increases the temporal
resolution of the images, albeit at the expense of spatial
resolution. The gain of the intensifier can be adjusted and is
usually kept at the minimum value that allows sufficient time
resolution. A higher intensifier gain significantly increases
noise during image acquisition. Although Fourier transform
and deconvolution programs are available to improve signal-tonoise ratios, we do not use such programs at the present time.
We currently use two CCD cameras [1]: a high-resolution
camera (CoolSnap HQ, Roper Scientific, Tucson AZ) which
captures images in 1390  1024 format; this camera has a high
readout rate and pixel dimensions of 6.6 mm  6.6 mm [2]; a
high-speed camera (Sensicam, Cooke Corporation, Auburn
Hill, MI) with a resolution of 640  480 and pixel dimensions
of 9.9 mm; while this latter camera has a lower spatial resolution, its smaller format allows a faster frame rate. Without
binning, the Sensicam can operate at frame rates of 30 images s1 and the CoolSnap HQ can operate at frame rates of 10
images s1 during capture of a fluorescent image in a single
channel. In order to increase the frame rate, the image acquisition software permits binning, i.e. the combination of signal
from 4 (2  2 binning) or 16 (4  4 binning) adjacent pixels.
Again, this combines light in adjacent pixels at the expense of
resolution. Binning also dramatically reduces the file size for
computer storage. We have found that 2  2 binning with the
high-speed camera, while keeping the light requirement low
enough for most applications, still allows us to record images
with an acceptable resolution and represents an optimal compromise for most of our experiments. A schematic representation of the microscope and its components are shown in Fig. 1.
The use of digital cameras has numerous benefits, providing
the potential to do quantitative two-dimensional fluorescence
experiments. Optical three-dimensional images can be generated, volumes determined and intensity of fluorochromes measured as a function of time, for example.

64 A. Celi et al

Fig. 1. Schematic diagram of the design of
the confocal and widefield instrument for
intravital microscopic imaging (modified from
Falati et al. Nat. Med. [7]).

Video acquisition
The images captured by the CCD cameras are transferred to the
random access memory of the computer. The Dell workstation
currently in use has dual 1 GHz processors, 1.5 GB of RAM,
two SCSI hard drives (18 GB and 73 GB) and a Nvidia video
card, and allows real-time recording of the data while connected
online to the CCD cameras. A second offline workstation with
similar configuation is used exclusively for image analysis so as
not to interfere with data collection. Imaging software (Slidebook, Intelligent Imaging Innovations, Denver, CO, USA) is
used to control and coordinate the hardware components (such
as the brightfield shutter, the high-speed wavelength changer,
the piezoelectric driver, the CCD camera, image acquisition
channel, etc.) during image acquisition and is also used for
image analysis.
Digital video analysis
For each frame, the software provides a graphical representation
(histogram) of the dynamic range of intensities within the
image. Since images are captured at a 12-bit depth, 212
(¼ 4096) levels of intensity are available. The histogram presents the number of pixels (y axis) at each level of intensity (x
axis). In order to differentiate subtle changes in intensity, it is
important to take advantage of the full dynamic range. This
requires changing the amount of light that reaches the camera,
which in turn is obtained by changing light intensity, the
intensifier gain, exposure time and binning. If too much light
reaches the CCD camera, all pixels with an intensity above 4096
will be recorded as equal; if not enough light is available, some
pixels will not be distinguishable from background noise due to
autofluorescence. In a typical experiment, after the first thrombus is generated, several short videos are recorded, with changes
to the above mentioned parameters until the optimal combina-

tion is obtained. If more than one fluorochrome is used, light
intensity and exposure time can be optimized for each wavelength, while binning and intensifier gain must be kept constant
throughout the experiment. In addition, if more than one
fluorochrome is used, crossover from one channel to the other
must be minimized or eliminated.
Many of our experiments involve the comparison of signals
generated by specific antibodies with those generated by isotype-matched control antibodies or non-immune IgG when
polyclonal antibodies are used. For the initial experiment in
a series, a non-immune isotype-matched antibody, labeled by
identical methods as the specific antibody, is injected, and a
thrombus is generated. The intensifier gain, exposure time and
binning are adjusted to minimize or eliminate the signal given
by non-specific binding and background fluorescence of the
non-immune antibody and mouse tissue. These settings are then
used in an experiment using the specific antibody. The amount
of specific antibody used must be empirically determined by
titering antibody into the animal until an adequate signal is
observed. This often necessitates that the control experiment be
redone using the newly determined antibody concentration. The
process may be iterated several times before the ideal conditions
are found. These conditions include short exposure times in
each fluorescence channel to allow for good temporal resolution
and a wide dynamic range. The settings thus determined are
then maintained for all the experiments in a series. The image
intensifier requires about 1 h of warmup before any readings are
taken since intraexperiment readings can vary by as much as
20% if this device is not warmed up.
More often than not, the optimized settings still are associated with some small signal observed in the control experiments. This has necessitated the development of a method to
account for background signal. As we work with living tissue,
there is movement due to blood pressure pulsations, small
muscle contractions, and the vessel reacting to the heat from
# 2003 International Society on Thrombosis and Haemostasis
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ablation. In addition, the background from the signal detected in
thrombi with non-immune isotype matched controls is determined from an entirely different preparation, not to mention that
every thrombus is different in size, shape and kinetics of growth.
Thus, we cannot subtract a background field (reference) from an
experimental field (sample). To deal with this issue, we use the
gray-scale histogram. Looking at histograms for the non-immune control antibodies, we establish a threshhold: the cut-off
value below which 95% of the signal falls. Applying this
threshhold when analyzing the data from the experimental
thrombi, we determine how much signal is above the background signal from the controls. We have found this method to

Fig. 2. Intravital widefield imaging of platelet,
tissue factor, and fibrin deposition in the
developing thrombus of a living wild-type
mouse following endothelial injury. Blood flow
is from right to left. Alexa 660-conjugated CD41
Fab fragments, Alexa 488-conjugated sheep
antitissue factor antibodies, and Alexa
350-conjugated mouse antihuman fibrin
antibodies were infused into the systemic
circulation. Thrombus components in four
separate channels were identified in
pseudocolors as well as a black and white
brightfield image, and a composite image
generated. To simplify analysis of the composite
image, the dynamic range of the intensity of
each pseudocolor was minimized. Platelets
(red); tissue factor (green); fibrin (blue);
platelets þ tissue factor (yellow); tissue factor þ
fibrin (turquoise); platelets þ fibrin (magenta);
platelets þ fibrin þ tissue factor (white). The
time, in seconds, indicates the approximate
interval from vessel wall injury to image
capture. This image is available as a videoclip
on http://wip.blackwellpublishing.com/products/
journals/suppmat/JTH/JTH33/JTH33sm.htm.
# 2003 International Society on Thrombosis and Haemostasis

yield satisfactory results, especially if the prethrombus histograms in both experimental and control fields are similar in
profile.
Thrombus formation
To compare the kinetics and localization of platelets, tissue
factor and fibrin in the thrombus in a living mouse, we performed intravital four-channel widefield fluorescence and
brightfield imaging (Fig. 2) [7]. At 0 s, the initial image immediately after injury shows minimal fluorescence. Subsequently,
platelets accumulate on the vessel wall. Tissue factor is also
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observed but the signal-to-noise level is too low to be certain
whether this initial signal is tissue factor-specific. With platelet
thrombus expansion, the quantity of fibrin and tissue factor,
particularly at the thrombus–vascular wall interface, increases.
The composited four-channel image indicates that platelets are
the major component of the arterial thrombus. Fibrin is localized on the vessel wall and then extends through part of the
thrombus during the period examined. In these images, tissue
factor is closely associated with fibrin.
Three dimensional reconstruction of a thrombus
High-speed confocal intravital microscopy has been used to
perform detailed structural analysis of the growing thrombus
generated by laser-induced injury. Using a piezo-electric driver
on the microscope objective lens, image ‘slices’ of 0.1–1 mm
can be obtain at a high frame rate. These slices are stacked, thus
generating an optical three dimensional computer reconstruction of the thrombus (Fig. 3; video).

Fig. 4. The kinetics of in vivo thrombus development. Platelets were
fluorescently labeled and a postcapillary venule of the cremaster muscle
was injured using the laser system. Confocal images of fluorescent
platelets in the thrombus were obtained sequentially using the
piezo-electric driver. The resulting 2D image were stacked in sequential
order with the imaging software to yield a 3D image of the thrombus.
Repeated 3D thrombus imaging allowed determination of thrombus
volume as a function of time. These experiments require digital confocal
microscopy and cannot be performed by widefield microscopy.

Thrombus volume determination
The volume of thrombi formed in vivo can be determined by
confocal microscopy and image analysis. In a thrombus, a three
dimensional thrombus image is obtained in which each component is labeled by a different fluorochrome. The total volume
of the thrombus is obtained by image analysis. The boundary
between the thrombus and the flowing blood is defined, and the
thrombus surface structure rendered. Pixels included within this
volume, including pixels defined by each of the fluorochromes
reporting each of the thrombus components, are totaled to yield
the number of ‘voxels.’ Since the dimension of a single pixel is
known for a given magnification and thus the voxel volume is
known, totaling of the number of voxels within a thrombus
yields the thrombus volume in mm3. To obtain the volume of a
thrombus component, such as platelets, the number of voxels
within the thrombus that are defined by the platelet-specific
fluorochrome are totaled (Fig. 4).
Thrombus embolization

Fig. 3. Three-dimensional image of a thrombus. An arteriole of the
cremaster muscle was injured. Images of fluorescent platelets in the
thrombus were obtained as the working distances between the objective
and the specimen were rapidly altered using the piezo-electric driver. At
each confocal plane, a 2D image was obtained. In this experiment,
confocal XY images were stacked in sequential order with the imaging
software to yield a 3D image of the thrombus. This image is available as a
videoclip on http://wip.blackwellpublishing.com/products/journals/
suppmat/JTH/JTH33/JTH33sm.htm.

The thrombi that are generated in the mouse microcirculation
undergo embolization, with small segments of the thrombus
breaking off and flowing downstream. To formally quantitate
this phenomenon, we have established methods for detecting
the image of the embolism as it floats downstream, and we can
quantitate the fluorochrome in the embolism (Fig. 5; video).
Using a high image capture rate of over 100 frames per second,
the integrated intensity of each thromboembolus is measured as
a function of time. This high capture rate is achieved using a
combination of 8  8 binning and limiting the region of interest.
The region of interest is that portion of the CCD chip-capturing
# 2003 International Society on Thrombosis and Haemostasis
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Fig. 5. Quantitation of thrombus
microembolization during thrombus formation.
The total amount of thromboemboli originating
from a thrombus has been quantitated by
widefield fluorescence microscopy. (A) In this
series, a thromboembolus digitally recorded at
9-ms intervals is pictured in the dashed box.
Thromboembolic events are captured by
defining a subarray of pixels downstream of
the thrombus with regard to blood flow. (B) The
integrated fluorescence of thromboemboli
entering the defined subarray over a period of
300 s is recorded. Each bar represents a unique
thromboembolic event.

signal related to embolization. The fluorochrome in the experiment shown was associated with platelets. Multiple embolic
events can be detected, and the amount of fluorochrome (proportional to the number of platelets) in each embolus is quantitated. This allows formal analysis of a series of events
observed previously using analog videomicroscopy, but which
could not be analyzed quantitatively and compared.
Image analysis and data interpretation
In designing and integrating the hardware for this system, it has
become abundantly clear to us that despite the complexity of the
components and their interfaces with each other, experimental
design and data interpretation are even more complex. Hidden
under the elegant images that emerge from these experiments is
the travail in design, execution, balance, and interpretation.
What you see is not what you get! More accurately, as the sign at
the School of Cinema–Television at the University of Southern
California says, ‘Reality stops here’. The digital revolution, as
applied to imaging, can introduce artifacts and misconceptions,
and the investigator needs to be especially critical. Problems
that we have encountered with our system and resolved include:
(i) shuffling of channels (i.e. inappropriate assignment of
specific images to specific color channels); (ii) cross-over of
one fluorescent channel into another channel; (iii) image artifacts due to pixel saturation and software bugs; (iv) threedimensional reconstructions without proper definition of the
z axis and interpolation between image slices; (v) generation of
fluorescent images, even in multiple colors, does not include
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sufficient information for analysis and interpretation; inclusion
of the brightfield background provides histologic context to the
events monitored by fluorescence microscopy; (vi) unequal
labeling of control and experimental antibodies; and (vii)
perturbation of mouse physiology with an inhibitory antibody.
Problems that arise in these types of analyses regardless of the
system used include: (i) claims of colocalization in widefield
images because pixels contain signal from two channels,
although the source of the signals may be relatively nonadjacent
in the z axis (i.e. colocalization can only be determined by
confocal images); (ii) lack of a uniform definition for real-time
imaging (continuous images 4–5 frames s1 might serve as a
provisional definition); (iii) the rate of change in tissue architecture must be slow with respect to the image-capture rate; (iv)
inadequate management of background and non-specific binding; and (v) photobleaching of fluorochromes over time
competes with the accurate measurement of the kinetics of
concentration change of fluorescently labeled proteins or
cells.
Future directions
Using these methods, we are able to analyze the accumulation
of proteins and cells that participate in thrombus formation. We
are able to observe platelet recruitment, tissue factor accumulation and fibrin deposition during thrombus development, and to
compare the time course of platelet and fibrin assembly into the
thrombus [7]. Furthermore, we have demonstrated that tissue
factor, although distributed throughout much of the growing
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thrombus, is concentrated on the vessel wall–thrombus interface. In separate studies, we have shown that P-selectin, an
adhesion molecule expressed by activated platelets and stimulated
endothelial cells, colocalizes with platelets, indicating that platelets within the thrombus undergo activation and degranulation
under our experimental conditions [8]. We have also demonstrated
thattissuefactoraccumulation andfibrindepositioninthegrowing
thrombus is dependent upon both P-selectin and PSGL-1 since
these thrombus components are absent or nearly absent in mice
lacking these adhesion molecules [9]. Numerous other in vivo
studies, particularly those involving various genetically altered
mice, are in the preliminary stages of development.
We see a number of challenges ahead. Intrinsically fluorescently labeled components, particularly those in low concentration and not optimal targets for antibody-based labeling,
would be ideal. We have used green fluorescent protein-containing platelets, prepared by replacement of the Gz gene with GFP
[10], as one approach to generating fluorescently tagged platelets without the use of exogenous fluorochromes. On a separate
front, we are examining the antithrombotic potential of several
small molecules using this thrombosis model, with special
emphasis on how they contribute to diminished thrombus size
[11].
To fully exploit the potential of this new system, we are
working to develop quantitative assays to translate color intensity in confocal images into fluorochrome concentration.
Such analysis is only possible in confocal mode since rigorous
quantitation requires the summation of the thin image slices
that, added together, represent the three-dimensional structure.
This would allow meaningful comparison of color intensities in
three channels; intensities could be converted into concentration of thrombus components. We also await improvement in
CCD camera technology and intensifier technology, both of
which will lead to higher resolution and faster frame-rates of
image capture. In addition, improved control over the emission
wavelength or filter coatings would offer improvements in color
separation and the potential for introduction of an additional
fluorescence channel.
Conclusion
Direct visualization of in vivo processes, including thrombus
formation, leukocyte rolling, and blood coagulation, offers new
potential for understanding of complex biological processes
such as hemostasis, thrombosis and inflammation. Coupled with
novel mouse strains and murine models of human disease,
opportunity exists for examining biochemical, physiologic
and pathologic processes in living animals.
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